J B Chemicals & Pharmaceuticals Ltd (JBCHEPHARM)
₹2,408.90
Mkt cap
₹38,677 Cr
P/E ratio
53.80
P/B
9.30
Div yield
0.91%
ROE
18.90%
ROCE
25.40%
EPS (TTM)
₹44.78
Book value
₹259
52W range
1,604–2,510
Sector
Healthcare
Price history
Previous close
J.B. Chemicals and Pharmaceuticals Limited, established in 1976, is one of India's leading pharmaceutical companies. An integrated, publicly-listed organization with a focus on supplying affordable, quality products both in India and internationally, JBCPL is trusted by healthcare professionals globally. [1]
NSE JBCHEPHARM
Health check
Constructive
ValuationExpensive
ProfitabilityStrong
GrowthModerate
TechnicalsBullish
52-week range
−4.03% from high₹2,409
₹1,604+50.23% from low₹2,510
Current
₹2,408.90
Prev close
₹2,506.00
Day
−3.87%
Price performance
1D
−3.59%
1W
−1.16%
1M
+10.18%
3M
+21.96%
6M
+26.43%
1Y
+48.65%
YTD
+30.18%
Financials
Revenue, profit & margin
P/E ratio
53.8×
JBCHEPHARM is 56% above the sector median of 34.5×
JBCHEPHARM53.8×
Sector median34.5×
| Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 762 | 896 | 882 | 845 | 862 | 1,004 | 1,001 | 963 | 949 | 1,094 | 1,085 | 1,065 | 904 | |
| Expenses | 599 | 664 | 638 | 621 | 664 | 724 | 730 | 709 | 723 | 793 | 775 | 769 | 703 | |
| Operating Profit | 164 | 232 | 244 | 223 | 198 | 280 | 271 | 255 | 226 | 301 | 310 | 296 | 201 | |
| OPM % | 21% | 26% | 28% | 26% | 23% | 28% | 27% | 26% | 24% | 28% | 29% | 28% | 22% | |
| Other Income | 5 | 6 | 8 | 7 | 17 | 6 | 10 | 8 | 14 | 15 | 15 | 18 | -15 | |
| Interest | 14 | 12 | 10 | 12 | 9 | 6 | 2 | 3 | 1 | 1 | 1 | 2 | 1 | |
| Depreciation | 32 | 31 | 32 | 34 | 41 | 41 | 42 | 42 | 46 | 43 | 44 | 45 | 50 | |
| Profit before tax | 122 | 194 | 209 | 184 | 165 | 240 | 237 | 218 | 193 | 272 | 279 | 267 | 135 | |
| Tax % | 28% | 27% | 28% | 27% | 23% | 26% | 26% | 25% | 25% | 25% | 26% | 26% | 25% | |
| Net Profit | 88 | 142 | 151 | 134 | 126 | 177 | 175 | 162 | 146 | 202 | 208 | 198 | 101 | |
| EPS in Rs | 5.66 | 9.19 | 9.72 | 8.62 | 8.13 | 11.39 | 11.24 | 10.45 | 9.36 | 12.96 | 13.27 | 12.63 | 6.31 | |
| Raw PDF |
Earnings
Results dates & reactionsNo upcoming results date on calendar.
Fresh quarters land in the Financials table above, tagged NSE until screener catches up.
Avg earnings-day move +0.31% · closed higher next day 26 of last 61
| Q1FY24 | Q2FY24 | Q3FY24 | Q4FY24 | Q1FY25 | Q2FY25 | Q3FY25 | Q4FY25 | Q1FY26 | Q2FY26 | Q3FY26 | Q4FY26† | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Broadcast | 10 Aug '23 | 8 Nov '23 | 7 Feb '24 | 18 May '24 | 8 Aug '24◦ | 6 Nov '24◦ | 5 Feb '25 | 14 May '25◦ | 30 Jul '25◦ | 11 Nov '25◦ | 16 Jan '26◦ | 11 May '26◦ |
| Earnings day | −0.01% | +0.65% | +4.33% | +0.99% | −0.88% | −1.11% | −1.63% | +1.63% | −0.75% | −0.49% | +1.19% | −3.35% |
| +1 day | −1.15% | +3.48% | +2.32% | −2.82% | −0.11% | −2.13% | −1.48% | +2.14% | −2.50% | −0.54% | −1.03% | −5.20% |
| +5 days | −1.59% | +3.43% | −2.85% | −2.35% | −0.18% | −10.57% | −6.66% | +4.47% | −5.23% | −4.18% | −1.39% | −1.70% |
| +15 days | +3.14% | +0.53% | −7.25% | +3.08% | +1.18% | −6.47% | −9.43% | +5.38% | −1.95% | −3.55% | +1.00% | −3.13% |
| +30 days | +5.71% | +11.43% | −6.15% | −1.98% | +0.23% | −1.12% | −5.27% | +8.66% | −5.79% | −0.71% | +7.76% | +1.08% |
| Filing | XBRL | XBRL | XBRL | XBRL | XBRL | XBRL | XBRL | XBRL | XBRL |
Corporate actions
Last 6 months| Kind | Value | Ex-date | Record |
|---|---|---|---|
| dividend Dividend - Rs 9.30 Per Share | 9.30 | 29 May '26 | 29 May '26 |
Results analysis
Shareholding
as of Mar 202648.80%Promoter
Promoters48.80%1.25
FIIs16.33%1.45
DIIs21.38%1.97
Public13.48%0.73
Government0.00%
Ownership trend
Peers
8 companiesValuation vs quality
P/E × ROCE · bubble = market cap| Name | CMP | P/E | Mkt Cap | Div Yld | NP Qtr | Qtr Profit Var | Sales Qtr | Qtr Sales Var | ROCE |
|---|---|---|---|---|---|---|---|---|---|
| Sun Pharma.Inds. | ₹1,777.70 | 34.66 | 4,26,530 | 0.90% | 1,995 | −10.53% | 16,199 | +11.88% | 20.53% |
| Divi's Lab. | ₹9,780.00 | 87.14 | 2,59,628 | 0.31% | 902 | +65.50% | 3,080 | +27.80% | 21.97% |
| Torrent Pharma. | ₹4,613.40 | 80.83 | 1,75,479 | 0.82% | 534 | −10.03% | 4,979 | +50.79% | 15.19% |
| Laurus Labs | ₹2,405.50 | 97.00 | 1,29,972 | 0.08% | 436 | +126.43% | 2,206 | +33.44% | 17.76% |
| Zydus Lifesci. | ₹1,245.50 | 25.52 | 1,24,239 | 0.08% | 990 | −35.09% | 8,017 | +21.96% | 21.14% |
| Dr Reddy's Labs | ₹1,352.00 | 40.30 | 1,12,849 | 0.59% | 913 | −31.35% | 8,698 | −1.48% | 13.04% |
| Cipla | ₹1,378.90 | 35.87 | 1,11,397 | 0.94% | 852 | −35.05% | 7,404 | −2.44% | 15.49% |
| J B Chemicals & | ₹2,408.90 | 53.83 | 38,677 | 0.91% | 101 | −16.99% | 904 | −4.77% | 25.45% |
| Median: 159 Co. | ₹435.20 | 34.47 | 1,923 | 0.08% | 15 | +21.96% | 175 | +18.91% | 15.13% |
Filings
Annual reports15
Concall transcripts56
TranscriptMay 2026RECMay 2026TranscriptJan 2026PPTJan 2026RECJan 2026TranscriptNov 2025PPTNov 2025TranscriptAug 2025PPTAug 2025PPTJun 2025TranscriptMay 2025PPTMay 2025TranscriptFeb 2025PPTFeb 2025TranscriptNov 2024PPTNov 2024TranscriptAug 2024PPTAug 2024TranscriptMay 2024PPTMay 2024TranscriptFeb 2024PPTFeb 2024RECFeb 2024TranscriptDec 2023